Safety and protective effect of bifidobactérium spp. used as probiotic agent in vivo against enteropathogenic escherichia coli

  • Mahmoudi Fatima University of Es-Senia of Oran, Algeria
  • Hadadji Miloud University of Es-Senia of Oran, Algeria
  • Benlahcen Kheira University of Es-Senia of Oran, Algeria
Keywords: Bifidobacterium, inhibition of enteric pathogens, antagonism effect

Abstract

This study showed the effect of fermented milk with Bifidobacterium bifidum on the contaminations by Escherichia coli enteropathogenic EPEC and intestinal disorders. The B. bifidum strain (Bf) was isolated on MRS medium containing 0.5g/L of cysteine hydrochloride and 2 mg/L of nalidixic acid. This strain was isolated from breastfed infant feces. This strain is considered as a model strain, for antagonism in vivo developed in the rat (wistar). It has has been demonstrated that the administration of Bifidobacterium strain cause a significant reduction of the rate of E. coli enteropathogenic multiplication in the rats feces. Results of the macroscopic study of histological sections have confirmed the positive effect of treatment with bifidobacteria. In this study, the effect of Bifidobacterium addition in reducing the enteropathogenic bacteria effect in the digestive tract was confirmed by in vitro and in vivo conditions.

Published
2015-06-02
How to Cite
1.
Fatima M, Miloud H, Kheira B. Safety and protective effect of bifidobactérium spp. used as probiotic agent in vivo against enteropathogenic escherichia coli. Innovative Romanian Food Biotechnology [Internet]. 2Jun.2015 [cited 29Apr.2024];(16):37-1. Available from: https://www.gup.ugal.ro/ugaljournals/index.php/IFRB/article/view/3501
Issue
No 16 (2015)
Section
Articles

Most read articles by the same author(s)

Obs.: This plugin requires at least one statistics/report plugin to be enabled. If your statistics plugins provide more than one metric then please also select a main metric on the admin's site settings page and/or on the journal manager's settings pages.